JP

Tsutomu Inoue

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsutomu Inoue. Retrieved from https://idiyas.com/inventor/tsutomu-inoue-w60dcjob

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Tsutomu Inoue: Innovator in Quinoline Sulfonoamino Compounds

Introduction

Tsutomu Inoue is a notable inventor from Japan, recognized for his contributions to the field of medicinal chemistry. His work primarily focuses on the development of quinoline sulfonoamino compounds that exhibit significant biological activities.

Latest Patents

Inoue's most recent patent is titled "Quinoline Sulfonoamino Compounds Having Vessel Smooth Muscle Relaxation Activity." This invention discloses a compound represented by a specific formula, where various groups are selected to enhance the compound's effectiveness. These compounds are known for their vessel smooth muscle relaxation activity, as well as their ability to inhibit platelet agglutination and various protein kinases. Notably, Inoue holds 0 patents.

Career Highlights

Throughout his career, Tsutomu Inoue has worked with prominent figures in the industry, contributing to significant advancements in his field. He has collaborated with Hiroyoshi Hidaka and Tomohiko Ishikawa, both of whom are recognized for their expertise in medicinal chemistry.

Collaborations

Inoue's collaborations with Hiroyoshi Hidaka and Tomohiko Ishikawa have been instrumental in his research endeavors. Their combined efforts have led to innovative approaches in the development of therapeutic compounds.

Conclusion

Tsutomu Inoue's work in the field of quinoline sulfonoamino compounds showcases his dedication to advancing medicinal chemistry. His contributions have the potential to impact various therapeutic applications significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…